Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: Clinical characteristics and outcome

Biology of Blood and Marrow Transplantation

Volumn 9, Issue 11, 2003, Pages 698-705

  Hale, Gregory A ^a,b   Rochester, R J ^a   Heslop, H E ^a,b   Krance, R A ^a,b   Gingrich, J R ^a,b   Benaim, E ^a,b   Horwitz, E M ^a,b   Cunningham, J M ^a,b   Tong, X ^a   Srivastava, D K ^a   Leung, W H ^a,b   Woodard, P ^a,b   Bowman, L C ^a,b   Handgretinger, R ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Adenovirus; Bone marrow transplantation; Complications; Hemorrhagic cystitis; Pediatrics

Indexed keywords

ALUMINUM POTASSIUM SULFATE; BUSULFAN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ESTROGEN; FORMALDEHYDE; GANCICLOVIR; IMMUNOGLOBULIN; MESNA; METHOTREXATE; PENTOXIFYLLINE; SILVER NITRATE; THYMOCYTE ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HEMORRHAGIC CYSTITIS; HIGH RISK PATIENT; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVING DONOR; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIPLE REGRESSION; MYELODYSPLASTIC SYNDROME; PNEUMOCYSTIS PNEUMONIA; RISK FACTOR; SEX DIFFERENCE; SIBLING; STATISTICAL ANALYSIS; T LYMPHOCYTE; UNITED STATES; WHOLE BODY RADIATION;

ACUTE DISEASE; ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CYSTITIS; FAMILY; GRAFT VS HOST DISEASE; HEMORRHAGIC DISORDERS; HUMANS; INFANT; LIVING DONORS; LYMPHOCYTE TRANSFUSION; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 9144226195     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1083-8791(03)00269-6     Document Type: Article

References (39)

1. Seber A. Shu X.O. Defor T. et al. Risk factors for severe hemorrhagic cystitis following BMT Bone Marrow Transplant 23 1999 35-40
2. Trotman J. Nivison-Smith I. Dodds A. Haemorrhagic cystitis: incidence and risk factors in a transplant population using hyperhydration Bone Marrow Transplant 23 1999 797-801
3. Turkeri L.N. Lum L.G. Uberti J.P. et al. Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous bladder irrigation J Urol 153 1995 637-640
4. Azzi A. Cesaro S. Laszlo D. et al. Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients J Clin Virol 14 1999 79-86
5. Leung A.Y.H. Suen C.K.M. Lie A.K.W. et al. Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation Blood 98 2001 1971-1978
6. Talar-Williams C. Hijazi Y.M. Walther M.M. et al. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis Ann Intern Med 124 1996 477-484
7. Hongeng S. Krance R.A. Bowman L.C. et al. Outcomes of transplantation with matched sibling and unrelated-donor bone marrow in children with leukemia Lancet 350 1997 767-770
8. Glucksberg H. Storb R. Fefer A. et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors Transplantation 18 1974 295-304
9. Heslop H.E. Benaim E. Brenner M.K. et al. Response of steroid-resistant graft-versus-host disease to lymphoblast antibody CBL1 Lancet 346 1995 805-806
10. Rooney C.M. Smith C.A. Ng C.Y. et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients Blood 92 1998 1549-1555
11. Prentice R.L. Kalbfleisch J.D. Peterson A.V. Jr. et al. The analysis of failure times in the presence of competing risks Biometrics 34 1978 541-554
12. Gray R.J. A class of k-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141-1154
13. Fine J.P. Gray R.J. A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496-509
14. Cox P.J. Cyclophosphamide cystitis-identification of acrolein as the causative agent Biochem Pharmacol 28 1979 2045-2049
15. Al-Rawithi S. El-Yazigi A. Ernst P. et al. Urinary excretion and pharmacokinetics of acrolein and its parent drug cyclophosphamide in bone marrow transplant patients Bone Marrow Transplant 22 1998 485-490
16. Hale G.A. Heslop H. Krance R. et al. Adenovirus infection after pediatric bone marrow transplantation Bone Marrow Transplant 23 1999 277-281
17. Rocha V. Labopin M. Gluckman E. et al. Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey J Clin Oncol 20 2002 4324-4330
18. Rabenau H.F. Preiser W. Franck S. et al. Polyomavirus viruria in bone marrow transplant recipients: lack of correlation with clinical symptoms Infection 30 2002 91-93
19. Baldwin A. Kingman H. Darville M. et al. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation Bone Marrow Transplant 26 2000 1333-1338
20. Chakrabarti S. Collingham K.E. Stevens R.H. et al. Isolation of viruses from stools in stem cell transplant recipients: a prospective surveillance study Bone Marrow Transplant 25 2000 277-282
21. Kondo M. Kojima S. Kato K. et al. Late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in children Bone Marrow Transplant 22 1998 995-998
22. Longergan T.A. Walzak M.P. Hemorrhagic cystitis due to adenovirus infection following bone marrow transplantation J Urol 151 1994 1013-1014
23. Echavarria M. Herrera F. Solimano J. et al. Cyclic recovery of adenovirus in a stem cell transplant recipient: an inverse association with graft-verus-host disease Bone Marrow Transplant 31 2003 301-303
24. Cragg L. Blazar B.R. Defor T. et al. A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease Biol Blood Marrow Transplant 6 2000 441-447
25. Bashey A. Immunosuppression with limited toxicity: the characteristics of nucleoside analogs and anti-lymphocyte antibodies used in non-myeloablative hematopoietic cell transplantation Cancer Treat Res 110 2002 3949
26. Nakai K. Kanda Y. Mineishi S. et al. Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin Bone Marrow Transplant 29 2002 237-241
27. Bacigalupo A. Lamparelli T. Bruzzi P. et al. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO) Blood 98 2001 2942-2947
28. Spach D.H. Bawens J.E. Myerson D. et al. Cytomegalovirus-induced hemorrhagic cystitis following bone marrow transplantation Clin Infect Dis 16 1993 142-144
29. Bedi A. Miller C.B. Hanson J.L. et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation J Clin Oncol 13 1995 1103-1109
30. Rice S.J. Bishop J.A. Apperley J. et al. BK virus as cause of haemorrhagic cystitis after bone marrow transplantation Lancet 2 1985 844-845
31. Vianelli N. Renga M. Azzi A. et al. Sequential vidarabine infusion in the treatment of polyoma virus-associated acute haemorrhagic cystitis late after allogeneic bone marrow transplantation Bone Marrow Transplant 25 2000 319-320
32. Lui Y.K. Harty J.I. Steinbock G.S. et al. Treatment of radiation or cyclophosphamide induced hemorrhagic cystitis using conjugated estrogen J Urol 144 1990 41-43
33. Vogeli T.A. Pienemann F. Burdach S. Ackermann R. Urological treatment and clinical course of BK polyomavirus-associated hemorrhagic cystitis in children after bone marrow transplantation Eur Urol 36 1998 252-257
34. Ordemann R. Naumann R. Geissler G. et al. Encouraging results in the treatment of haemorrhagic cystitis with estrogen-report of 10 cases and review of the literature Bone Marrow Transplant 25 2000 981-985
35. Gonzalez-Fraile M.I. Canizo C. Caballero D. et al. Cidofovir treatment of human polyomavirus-associated acute haemorrhagic cystitis Transpl Infect Dis 3 2001 44-46
36. Vela-Ojeda J. Tripp-Villanueva F. Sanchez-Cortes E. et al. Intravesical rhGM-CSF for the treatment of late onset hemorrhagic cystitis after bone marrow transplant Bone Marrow Transplant 24 1999 1307-1310
37. Demesmay K. Tissot E. Bulabois C.E. et al. Factor XIII replacement in stem-cell transplant recipients with severe hemorrhagic cystitis: a report of four cases Transplantation 74 2002 1190-1192
38. Garderet L. Bittencourt H. Sebe P. et al. Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipients Transplantation 70 2000 1807-1811
39. Handgretinger R. Klingebiel T. Lang P. et al. Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children Bone Marrow Transplant 27 2001 777-783